Intermittent use of topical dimethyl sulfoxide in macular and papular amyloidosis

International Journal of Dermatology

Volumn 37, Issue 12, 1998, Pages 949-954

  Özkaya Bayazit, Esen ^a,b   Kavak, Ayşe ^a   Güngör, Havva ^a   Özarmagan, Güzin ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

DIMETHYL SULFOXIDE;

ADULT; AMYLOIDOSIS; ARTICLE; BURN; CLINICAL ARTICLE; CONTACT URTICARIA; CONTROLLED STUDY; DESQUAMATION; FEMALE; FOLLOW UP; HALITOSIS; HISTOPATHOLOGY; HUMAN; MALE; PAPULE; PIGMENTATION; PRURITUS; SCORING SYSTEM; SKIN BIOPSY; SKIN DISEASE;

ADMINISTRATION, TOPICAL; ADULT; AMYLOIDOSIS; DIMETHYL SULFOXIDE; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PRURITUS; SKIN DISEASES;

EID: 0032410671     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.1998.00600.x     Document Type: Article

References (27)

1. Brownstein MH, Hashimoto K, Greenwald G. Biphasic amyloidosis: link between macular and lichenoid forms. Br J Dermatol 1973; 88: 15-19.
2. Bonnetblanc JM, Gatanzano G, Roux I. DMSO and macular amyloidosis. Acta Derm Venereol (Stockh) 1980; 60: 91.
3. Monfrecola G, Iandoli R, Bruno G, Martellotta D. Lichen amyloidosis: a new therapeutic approach. Acta Derm Venereol (Stockh) 1985; 65: 453-455.
4. Ollague W. Primary cutaneous amyloidosis (letter). Int J Dermatol 1987; 26: 135.
5. Pravata G, Pinto G, Basco M, et al. Unusual localization of lichen amyloidosis. Acta Derm Venereol (Stockh) 1989; 69: 159-160.
6. Özkaya-Bayazit E, Baykal C, Kavak A. Topical DMSO treatment of macular and papular amyloidosis. Hautarzt 1997; 48: 31-37.
7. Hashimoto K, Ito K, Kumakiri M, Headington J. Nylon brush macular amyloidosis. Arch Dermatol 1987; 123: 633-637.
8. Weyers W, Weyers I, Bonczkowitz M, et al. Lichen amyloidosis: a consequence of scratching. J Am Acad Dermatol 1997; 37: 923-928.
9. Wong CK, Lin CS. Friction amyloidosis. Int J Dermatol 1988; 27: 302-307.
10. Maeda H, Otha S, Saito Y, et al. Epidermal origin of the amyloid in localized cutaneous amyloidosis. Br J Dermatol 1981; 106: 345-351.
11. Hintner H, Stössl H, Höpfl R, et al. Amyloid K. Hautarzt 1988; 39: 419-425.
12. Iwasaki K, Mihara M, Nishiura S, Shimao S. Biphasic amyloidosis arising from friction melanosis. J Dermatol 1991; 18: 86-91.
13. Wong CK, Li WM. Dermabrasion for lichen amyloidosis. Arch Dermatol 1981; 118: 302-304.
14. Hudson LD. Macular amyloidosis: treatment with ultraviolet B. Cutis 1986; 38: 61-62.
15. Helander I, Hapsu VK. Treatment of lichen amyloidosis by etretinate. Clin Exp Dermatol 1986; 11: 574-577.
16. Aram H. Failure of etretinate (Ro 10-9359) in lichen amyloidosis. Int J Dermatol 1986; 25: 206.
17. Pasricha JS, Seetharam KA. Low dose cyclophosphamide therapy in lichen amyloidosis. Indian J Dermatol Venereol Leprol 1987; 53: 273-274.
18. Reynolds JEF. Martindale The Extra Pharmacopoeia, 30th edn. London: The Pharmaceutical Press, 1993; 1101-1102.
19. David NA. The pharmacology of dimethyl sulphoxide. Ann Rev Pharmacol 1972; 12: 353-374.
20. Brobyn RD. The human toxicology of dimethyl sulphoxide. Ann NY Acad Sci 1975; 243: 497-506.
21. Ravid M, Shapira J, Lang R, Kedar I. Prolonged dimethyl sulphoxide treatment in 13 patients with systemic amyloidosis. Ann Rheum Dis 1982; 41: 587-592.
22. Wong CK, Lin CS. Remarkable response of lipoid proteinosis to oral dimethyl sulphoxide. Br J Dermatol 1988; 119: 541-544.
23. Bonnetblanc JM, Bedane C. Regression of scleromyxedema with topical betamethasone and dimethyl sulphoxide: a 30-month follow-up. Arch Dermatol 1991; 127: 1733-1734.
24. Lim KB, Tan SH, Tan KT. Lack of effect of dimethyl sulphoxide (DMSO) on amyloid deposits in lichen amyloidosis. Er J Dermatol 1988; 119: 409-410.
25. Harman D. Secondary amyloidosis and antioxidants. Lancet 1980; I: 593.
26. Reinauer S, Goerz G. Juckreiz. Hautarzt 1996; 47: 229-242.
27. Kligman AM. Topical pharmacology and toxicology of dimethyl sulphoxide - Part 2. JAMA 1965; 193: 923-928.